Then, we found that the combined treatment could strongly attenuate the expression of NF-κb and enhance the expression of KLF-2, with the more effective hematoma absorption and a better outcome, compared with the monotreatment’s in the CSDH rat model at 5 d. The gene discussed is KLF2; the disease is hematoma.